TOMZ News & Analysis
2 articles
Market Mood
TOMI (TOMZ) Q1 2026 Revenue Up 5% Year-Over-Year with Backlog Growth
In Q1 2026, TOMI (TOMZ) reported a 5% year-over-year revenue increase and a significant 67% sequential revenue jump from Q4 2025. Notably, applicator sales grew by 139% year-over-year, exceeding total sales for 2025. The company also achieved a $296,000 positive operating cash flow, a $572,000 improvement year-over-year, while operating expenses decreased by 15%. TOMI's backlog expanded to $2.2 million, up by $0.5 million from the end of 2025, highlighting strong demand in their integrated system and service offerings.
Read More
TOMZ Achieves $500K Contract with Global Biopharmaceutical Leader
In the 2025 earnings call for TOMI Environmental Solutions (TOMZ), CEO Halden Shane reported significant milestones, including a $500,000 contract with a global biopharmaceutical leader for integration of their SteraMist Integration System in sterile manufacturing. By the end of 2025, TOMZ had secured four operational SIS installations. The company also made strides in the life sciences sector, winning a contract with NASA Johnson Space Center for biosecurity and expanding customer relationships in the eye health sector. These developments indicate growth potential and position TOMZ to capitalize on future revenue opportunities in 2026.
Read More